TNGX - Tango Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.83
DETAILS
HIGH:
$55.00
LOW:
$24.00
MEDIAN:
$31.50
CONSENSUS:
$34.83
UPSIDE:
72.08%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 62.4 | 42.1 | 36.5 | 24.9 | 37.0 | 7.7 | 24.6 |
| Cost of Revenue | 2.3 | 0 | 0 | 0 | 0 | 1.6 | 32.3 |
| Gross Profit | 60.1 | 42.1 | 36.5 | 24.9 | 37.0 | 6.0 | (7.6) |
| Operating Expenses | |||||||
| R&D Expenses | 132.2 | 143.9 | 115.2 | 105.9 | 77.6 | 50.0 | 32.3 |
| SG&A Expenses | 41.5 | 43.7 | 35.5 | 30.0 | 17.6 | 8.2 | 7.5 |
| Other Expenses | (2.3) | 0 | 0 | 0 | 0 | 0 | (32.3) |
| Operating Expenses | 171.4 | 187.7 | 150.7 | 135.9 | 95.2 | 58.2 | 7.5 |
| Operating Income | |||||||
| Operating Income | (111.3) | (145.6) | (114.2) | (111.1) | (58.2) | (52.2) | (15.2) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 5.6 | 7.9 | 6.6 | 1.5 | 0.5 | 0.1 | 0.7 |
| Profitability | |||||||
| EBITDA | (109.0) | (143.1) | (111.8) | (109.5) | (57.3) | (50.3) | (14.5) |
| EBIT | (111.3) | (145.6) | (114.2) | (111.1) | (58.2) | (52.0) | (15.2) |
| Income Before Tax | (101.6) | (130.1) | (101.6) | (108.1) | (57.9) | (52.0) | (14.1) |
| Income Tax Expense | 0.0 | 0.2 | 0.1 | 0.1 | 0.3 | 0 | 0 |
| Net Income | (101.6) | (130.3) | (101.7) | (108.2) | (58.2) | (52.0) | (14.1) |
| Per Share Data | |||||||
| EPS (Basic) | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| EPS (Diluted) | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| Shares Outstanding | 116.2 | 109.2 | 94.6 | 87.8 | 62.1 | 87.5 | 87.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 112.3 | 69.5 | 66.4 | 60.0 | 142.7 | 28.4 | 22.9 |
| Short-Term Investments | 230.9 | 188.4 | 270.5 | 306.2 | 342.5 | 161.9 | 17.5 |
| Net Receivables | 0 | 0 | 0 | 2 | 2 | 2 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.6 | 8.4 | 9.7 | 7.1 | 0.6 | 0 | 0 |
| Total Current Assets | 353.8 | 266.3 | 346.5 | 375.3 | 492.3 | 193.6 | 41.7 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 42.5 | 47.6 | 53.4 | 57.8 | 6.1 | 11.3 | 11.8 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.4 | 2.6 | 2.6 | 3.4 | 1.7 | 2.3 | 2.3 |
| Total Non-Current Assets | 44.9 | 50.1 | 56.0 | 61.2 | 7.8 | 13.6 | 14.1 |
| Total Assets | 398.7 | 316.5 | 402.6 | 436.5 | 500.2 | 207.3 | 55.8 |
| Current Liabilities | |||||||
| Account Payables | 1.2 | 1.6 | 2.8 | 4.5 | 3.2 | 1.8 | 0.7 |
| Short-Term Debt | 2.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 17.6 | 25.7 | 31.8 | 26.0 | 32.0 | 0 |
| Other Current Liabilities | 17.8 | 1.7 | 7.5 | 1.3 | 0.7 | 0.8 | 19.9 |
| Total Current Liabilities | 21.7 | 38.2 | 45.9 | 55.5 | 40.7 | 40.9 | 25.9 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 30.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0.0 | 14.1 |
| Total Non-Current Liabilities | 30.8 | 78.8 | 103.5 | 131.4 | 114.7 | 127.7 | 22.0 |
| Total Liabilities | 52.5 | 117.0 | 149.5 | 187.0 | 155.4 | 168.7 | 47.9 |
| Stockholders' Equity | |||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Retained Earnings | (603.2) | (501.6) | (371.3) | (269.5) | (161.3) | (103.1) | (51.1) |
| Accumulated Other Comprehensive Income | 0.2 | 0.3 | 0.2 | (3.7) | (0.8) | 0.0 | 0.0 |
| Total Stockholders' Equity | 346.2 | 199.5 | 253.1 | 249.5 | 344.7 | 38.6 | 7.9 |
| Total Liabilities & Equity | 398.7 | 316.5 | 402.6 | 436.5 | 500.2 | 207.3 | 55.8 |
| Debt Metrics | |||||||
| Total Debt | 33.6 | 36.5 | 38.9 | 41.1 | 1.5 | 7.9 | 8.5 |
| Net Debt | (78.7) | (33.0) | (27.5) | (18.8) | (141.2) | (20.5) | (14.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (101.6) | (130.3) | (101.7) | (108.2) | (58.2) | (52.0) | (14.1) |
| Depreciation & Amortization | 2.3 | 2.5 | 2.4 | 1.6 | 0.9 | 0.7 | 0.6 |
| Stock-Based Compensation | 26.4 | 28.9 | 19.1 | 14.2 | 7.8 | 1.8 | 1.7 |
| Change in Working Capital | (67.2) | (31.7) | (38.0) | (18.5) | (11.3) | 118.7 | 1.7 |
| Other Non-Cash Items | 1.2 | (0.8) | 0.2 | 1.8 | 1.3 | 0.9 | (14.7) |
| Operating Cash Flow | (138.9) | (131.5) | (118.0) | (109.1) | (59.5) | 70.1 | (24.8) |
| Investing Activities | |||||||
| Capital Expenditure | (1.0) | (0.8) | (1.5) | (7.7) | (1.8) | (1.1) | (1.8) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (264.5) | (240.9) | (310.6) | (208.5) | (372.4) | (207.5) | 0 |
| Sales/Maturities of Investments | 224.6 | 327.8 | 353.5 | 242.6 | 190.8 | 63.2 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | (0.0) | 2.7 |
| Investing Cash Flow | (40.9) | 86.1 | 41.4 | 26.4 | (183.4) | (145.5) | 0.8 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 342.1 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.0) | 5.9 | 2.4 | 1.6 | (14.8) | 0.0 | 11 |
| Financing Cash Flow | 222.5 | 47.7 | 82.4 | 1.6 | 357.3 | 80.9 | 11 |
| Cash Position | |||||||
| Net Change in Cash | 42.7 | 2.3 | 5.8 | (81.1) | 114.4 | 5.5 | 25.2 |
| Cash at Beginning | 72.1 | 69.8 | 64.0 | 145.0 | 30.7 | 25.2 | 0 |
| Cash at End | 114.8 | 72.1 | 69.8 | 64.0 | 145.0 | 30.7 | 25.2 |
| Free Cash Flow | (139.9) | (132.3) | (119.5) | (116.8) | (61.4) | 69.0 | (26.6) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 62.4 | 42.1 | 36.5 | 24.9 | 37.0 | 7.7 | 24.6 |
| Gross Profit | 60.1 | 42.1 | 36.5 | 24.9 | 37.0 | 6.0 | (7.6) |
| Operating Income | (111.3) | (145.6) | (114.2) | (111.1) | (58.2) | (52.2) | (15.2) |
| Net Income | (101.6) | (130.3) | (101.7) | (108.2) | (58.2) | (52.0) | (14.1) |
| EPS (Diluted) | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| Balance Sheet | |||||||
| Cash & Equivalents | 112.3 | 69.5 | 66.4 | 60.0 | 142.7 | 28.4 | 22.9 |
| Total Assets | 398.7 | 316.5 | 402.6 | 436.5 | 500.2 | 207.3 | 55.8 |
| Total Debt | 33.6 | 36.5 | 38.9 | 41.1 | 1.5 | 7.9 | 8.5 |
| Stockholders' Equity | 346.2 | 199.5 | 253.1 | 249.5 | 344.7 | 38.6 | 7.9 |
| Cash Flow | |||||||
| Operating Cash Flow | (138.9) | (131.5) | (118.0) | (109.1) | (59.5) | 70.1 | (24.8) |
| Capital Expenditure | (1.0) | (0.8) | (1.5) | (7.7) | (1.8) | (1.1) | (1.8) |
| Free Cash Flow | (139.9) | (132.3) | (119.5) | (116.8) | (61.4) | 69.0 | (26.6) |